GSK plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 76.61B |
| Enterprise value | 94.89B |
| Trailing P/E | 12.02 |
| Forward P/E | 9.75 |
| PEG ratio (5-yr expected) | 1.02 |
| Price/sales (ttm) | 2.13 |
| Price/book (mrq) | 4.91 |
| Enterprise value/revenue | 3.23 |
| Enterprise value/EBITDA | 10.27 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.30 |
| 52-week change 3 | 26.54% |
| S&P500 52-week change 3 | 14.91% |
| 52-week high 3 | 39.74 |
| 52-week low 3 | 28.78 |
| 50-day moving average 3 | 35.64 |
| 200-day moving average 3 | 35.43 |
Share statistics
| Avg vol (3-month) 3 | 3.34M |
| Avg vol (10-day) 3 | 4.01M |
| Shares outstanding 5 | 2.05B |
| Implied shares outstanding 6 | 2.07B |
| Float 8 | 1.96B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 13.60% |
| Shares short (14 Sept 2023) 4 | 5.57M |
| Short ratio (14 Sept 2023) 4 | 1.56 |
| Short % of float (14 Sept 2023) 4 | N/A |
| Short % of shares outstanding (14 Sept 2023) 4 | 0.27% |
| Shares short (prior month 14 Aug 2023) 4 | 5.26M |
Dividends & splits
| Forward annual dividend rate 4 | 1.4 |
| Forward annual dividend yield 4 | 3.75% |
| Trailing annual dividend rate 3 | 0.56 |
| Trailing annual dividend yield 3 | 1.47% |
| 5-year average dividend yield 4 | 5.16 |
| Payout ratio 4 | 46.22% |
| Dividend date 3 | 11 Oct 2023 |
| Ex-dividend date 4 | 16 Aug 2023 |
| Last split factor 2 | 1226:1000 |
| Last split date 3 | 21 July 2022 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 June 2023 |
Profitability
| Profit margin | 52.60% |
| Operating margin (ttm) | 27.17% |
Management effectiveness
| Return on assets (ttm) | 6.71% |
| Return on equity (ttm) | 33.22% |
Income statement
| Revenue (ttm) | 29.33B |
| Revenue per share (ttm) | 14.52 |
| Quarterly revenue growth (yoy) | 3.60% |
| Gross profit (ttm) | 19.92B |
| EBITDA | 9.87B |
| Net income avi to common (ttm) | 5.37B |
| Diluted EPS (ttm) | 3.10 |
| Quarterly earnings growth (yoy) | 93.80% |
Balance sheet
| Total cash (mrq) | 6.5B |
| Total cash per share (mrq) | 3.21 |
| Total debt (mrq) | 21.47B |
| Total debt/equity (mrq) | 176.61% |
| Current ratio (mrq) | 0.88 |
| Book value per share (mrq) | 6.26 |
Cash flow statement
| Operating cash flow (ttm) | 4.59B |
| Levered free cash flow (ttm) | 21.12B |
© 2023 Yahoo. All rights reserved.
